Aytu Biopharma (AYTU) Other Non-Current Liabilities (2015 - 2026)
Aytu Biopharma (AYTU) reported Other Non-Current Liabilities of $4.77 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 81.9% from $26.33 million a year earlier and down 1.4% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Other Non-Current Liabilities (2015 - 2026) Analysis & Trends
Dating back to fiscal Q3 2015, Aytu Biopharma's Other Non-Current Liabilities record includes 46 quarters.
- Other Non-Current Liabilities has a five-year compound annual growth rate of -23.7% (FY2021 to FY2026).
- By fiscal year, Other Non-Current Liabilities came in at $26.33 million in FY2025 (+106.6%), $12.75 million in FY2024 (+82.7%), $6.98 million in FY2023 (-45.5%) and $12.8 million in FY2022 (-30.8%).
- The fiscal Q4 2026 figure ranks as the lowest quarterly Other Non-Current Liabilities since fiscal Q1 2019.
- Year over year, Other Non-Current Liabilities gained in three of the last eight quarters, with growth averaging 43.9%.
- The high point for year-over-year Other Non-Current Liabilities in five years was fiscal Q2 2026 (growth of 328.1%); the low point was fiscal Q4 2026 (a decline of 81.9%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $4.84 million (Q3 2026), $27.34 million (Q2 2026) and $20.42 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Aytu Biopharma | 22.17 Mn | -93.50 Mn | 10.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.97 Mn |
| Mar 31, 2026 | 7.03 Mn |
| Dec 31, 2025 | 32.24 Mn |
| Sep 30, 2025 | 25.38 Mn |
| Jun 30, 2025 | 31.25 Mn |
| Mar 31, 2025 | 9.06 Mn |
| Dec 31, 2024 | 11.43 Mn |
| Sep 30, 2024 | 14.32 Mn |
| Jun 30, 2024 | 17.27 Mn |
| Mar 31, 2024 | 14.40 Mn |
| Dec 31, 2023 | 19.23 Mn |
| Sep 30, 2023 | 20.42 Mn |
| Jun 30, 2023 | 13.38 Mn |
| Mar 31, 2023 | 9.50 Mn |
| Dec 31, 2022 | 13.94 Mn |
| Sep 30, 2022 | 14.89 Mn |
| Jun 30, 2022 | 14.59 Mn |
| Mar 31, 2022 | 5.95 Mn |
| Dec 31, 2021 | 8.86 Mn |
| Sep 30, 2021 | 8.49 Mn |
API Access
Aytu Biopharma Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();